Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2020
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative PhenotypesMarshall S Goodwin, Olga Sinyavskaya, Franklin Burg, et al.
Plos One|July 5, 2013
Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brainParamita Chakrabarty, Awilda Rosario, Pedro Cruz, et al.
Molecular Therapy. Methods & Clinical Development|November 29, 2023
A C1qTNF3 collagen domain fusion chaperones diverse secreted proteins and anti-Aβ scFvs: Applications for gene therapiesBrenda D Moore, Yong Ran, Marshall S Goodwin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 28, 2006
Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse modelsYona Levites, Lisa A Smithson, Robert W Price, et al.
Nature Communications|August 23, 2012
Aβ alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivoLuxiang Cao, Benjamin R Schrank, Steve Rodriguez, et al.
Acta Neuropathologica Communications|March 7, 2025
Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulationEmily J Koller, Karen N McFarland, Conner Angelle, et al.
Alzheimer'S Research & Therapy|October 18, 2020
Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in DrosophilaLorena De Mena, Michael A Smith, Jason Martin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2014
Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS miceJacob I Ayers, Susan Fromholt, Olga Sinyavskaya, et al.
The Journal of Experimental Medicine|February 17, 2019
rAAV-based brain slice culture models of Alzheimer's and Parkinson's disease inclusion pathologiesCara L Croft, Pedro E Cruz, Daniel H Ryu, et al.
Pageof 6